149751-93-9

Basic information

• Product Name: Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-(methoxymethylamino)-4-oxo -, phenylmethyl ester, (3S)-
• CAS NO: 149751-93-9
• Molecular Formula: C18H26N2O6
• Molecular Weight: 366.414
• Mol File: 149751-93-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-(methoxymethylamino)-4-oxo -, phenylmethyl ester, (3S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-(methoxymethylamino)-4-oxo -, phenylmethyl ester, (3S)-(149751-93-9)
• EPA Substance Registry System: Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-(methoxymethylamino)-4-oxo -, phenylmethyl ester, (3S)-(149751-93-9)

Safety Data

• Hazardous Substances Data: 149751-93-9(Hazardous Substances Data)

Upstream product

• 7536-58-5 BOC-L-aspartic acid 4-benzyl ester 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 

Downstream Products

• 79069-52-6 N-Boc-L-aspartic aldehyde β-benzyl ester 
• 864510-39-4 2-isocyano-succinic acid 4-benzyl ester N-methoxy-N-methylamide 
• 864510-37-2 N^α-formyl-L-aspartic acid 4-benzyl ester N-methoxy-N-methylamide 
• 497831-00-2 (E)-(S)-4-tert-Butoxycarbonylamino-hex-2-enedioic acid 6-benzyl ester 1-ethyl ester 
• 497830-96-3 (E)-(S)-4-Benzylamino-hex-2-enedioic acid 6-benzyl ester 1-ethyl ester 
• 497830-82-7 (E)-(S)-4-[Benzyl-((E)-4-oxo-pent-2-enoyl)-amino]-hex-2-enedioic acid 6-benzyl ester 1-ethyl ester 
• 497830-74-7 (3S,3aR,4S,7aR)-2-benzyl-3-benzyloxycarbonylmethyl-6-methyl-1-oxo-1,2,3,3a,4,7a-hexahydro-pyrano[3,4-c]pyrrole-4-carboxylic acid ethyl ester 
• 497830-84-9 (E)-(S)-4-[Benzyl-((E)-4-oxo-4-phenyl-but-2-enoyl)-amino]-hex-2-enedioic acid 6-benzyl ester 1-ethyl ester 
• 497830-75-8 (3S,3aR,4S,7aR)-2-benzyl-3-benzyloxycarbonylmethyl-1-oxo-6-phenyl-1,2,3,3a,4,7a-hexahydro-pyrano[3,4-c]pyrrole-4-carboxylic acid ethyl ester 

Relevant articles and documents

Template synthesis of peptidomimetics composed of aspartic acid moiety by ugi four-component condensation reaction

Caspase-3 inhibitors were supposed to be of benefit to both acute and chronic neurodegenerative conditions. In this work, a CPP32-peptidomimetic- inhibitor library was designed. The necessary aspartate moiety was reserved at the C terminal. A facile and v